Status:
COMPLETED
Indocyanine Green for Solid Tumors
Lead Sponsor:
University of Pennsylvania
Conditions:
Solid Tumor
Neoplasms
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
According to the World Health Organization, cancer is a leading cause of death in men and women, accounting for 7.6 million deaths (around 13% of all deaths) in 2008. Surgery remains the best option f...
Eligibility Criteria
Inclusion
- Adult patients over 18 years of age
- Patients presenting with a solid tumor presumed to be resectable cancer and are at risk for local recurrence on pre-operative assessment
- Good operative candidate as determined by the treating physician and multidisciplinary team
- Subject capable of giving informed consent and participating in the process of consent.
Exclusion
- Pregnant women as determined by urinary or serum beta hCG within 72 hours of surgery
- Subjects with a history of iodide allergies
- Vulnerable patient populations
- People who would be easily lost to follow up
- Patients unable to participate in the consent process (children and neonates).
Key Trial Info
Start Date :
November 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2017
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT02280954
Start Date
November 1 2013
End Date
February 1 2017
Last Update
March 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104